Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 5:23 pm Purchase | 2021-02-04 | 13D | Landos Biopharma, Inc. LABP | RTW Investments, LP | 427,572 10.660% | 427,572 (New Position) | Filing History |
| 2021-02-16 10:37 am Purchase | 2020-12-31 | 13G | Immunovant, Inc. IMVT | RTW Investments, LP | 7,592,253 7.750% | 7,592,253 (New Position) | Filing History |
| 2021-02-16 10:35 am Purchase | 2020-12-31 | 13G | Helix Acquisition Corp. HLXA | RTW Investments, LP | 750,000 6.290% | 750,000 (New Position) | Filing History |
| 2021-02-16 10:33 am Purchase | 2020-12-31 | 13G | Frequency Therapeutics, Inc. FREQ | RTW Investments, LP | 49,230 7.300% | 49,230 (New Position) | Filing History |
| 2021-02-16 10:31 am Purchase | 2020-12-31 | 13G | Vincerx Pharma, Inc. VINC | RTW Investments, LP | 37,500 5.360% | 37,500 (New Position) | Filing History |
| 2021-02-16 10:29 am Purchase | 2020-12-31 | 13G | LifeSci Acquisition II Corp. LSAQ | RTW Investments, LP | 650,000 6.580% | 650,000 (New Position) | Filing History |
| 2021-02-16 10:26 am Purchase | 2020-12-31 | 13G | FIVE PRIME THERAPEUTICS INC FPRX | RTW Investments, LP | 2,515,788 5.730% | 2,515,788 (New Position) | Filing History |
| 2021-02-12 10:15 am Purchase | 2020-12-31 | 13G | IVERIC bio, Inc. ISEE | RTW Investments, LP | 6,722,624 7.510% | 600,742 (+9.81%) | Filing History |
| 2021-02-12 10:12 am Unchanged | 2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | RTW Investments, LP | 2,071,409 7.540% | 0 (Unchanged) | Filing History |
| 2021-02-12 10:08 am Sale | 2020-12-31 | 13G | Homology Medicines, Inc. FIXX | RTW Investments, LP | 0 0.000% | -241,625 (Position Closed) | Filing History |
| 2021-02-12 10:06 am Purchase | 2020-12-31 | 13G | Establishment Labs Holdings Inc. ESTA | RTW Investments, LP | 2,319,138 9.890% | 286,692 (+14.11%) | Filing History |
| 2021-02-12 10:01 am Purchase | 2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | RTW Investments, LP | 7,253,857 9.670% | 1,379,628 (+23.49%) | Filing History |
| 2021-02-12 09:58 am Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | RTW Investments, LP | 1,998,750 3.170% | 740,000 (+58.79%) | Filing History |
| 2021-02-12 09:55 am Purchase | 2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 3,958,130 8.190% | 208,023 (+5.55%) | Filing History |
| 2021-02-12 09:52 am Purchase | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RTW Investments, LP | 3,422,855 8.660% | 1,537,855 (+81.58%) | Filing History |
| 2021-02-12 09:51 am Purchase | 2021-02-12 | 13G | Exagen Inc. XGN | RTW Investments, LP | 1,250,131 9.890% | 348,046 (+38.58%) | Filing History |
| 2021-02-12 09:49 am Sale | 2020-12-31 | 13G | Wave Life Sciences Ltd. WVE | RTW Investments, LP | 0 0.000% | -2,414,027 (Position Closed) | Filing History |
| 2021-02-12 09:47 am Purchase | 2020-12-31 | 13G | Vericel Corporation VCEL | RTW Investments, LP | 4,517,570 9.940% | 1,528,141 (+51.12%) | Filing History |
| 2021-02-12 09:46 am Purchase | 2020-12-31 | 13G | TELA Bio, Inc. TELA | RTW Investments, LP | 1,383,816 9.590% | 244,458 (+21.46%) | Filing History |
| 2021-02-12 09:44 am Sale | 2020-12-31 | 13G | Telesis Bio, Inc. TBIO | RTW Investments, LP | 165,468 4.010% | -18,132 (-9.88%) | Filing History |